134 related articles for article (PubMed ID: 14607707)
1. D-galactosamine based canine acute liver failure model.
Patzer JF; Block GD; Khanna A; Yin WY; Molmenti E; Gerber D; Kramer DJ; Scott VL; Aggarwal S; Wagner RA; Fulmer ML; Amiot BP; Mazariegos GV
Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):354-67. PubMed ID: 14607707
[TBL] [Abstract][Full Text] [Related]
2. An anesthetized model of lethal canine galactosamine fulminant hepatic failure.
Sielaff TD; Hu MY; Rollins MD; Bloomer JR; Amiot B; Hu WS; Cerra FB
Hepatology; 1995 Mar; 21(3):796-804. PubMed ID: 7875678
[TBL] [Abstract][Full Text] [Related]
3. Novel bioartificial liver support system: preclinical evaluation.
Patzer JF; Mazariegos GV; Lopez R; Molmenti E; Gerber D; Riddervold F; Khanna A; Yin WY; Chen Y; Scott VL; Aggarwal S; Kramer DJ; Wagner RA; Zhu Y; Fulmer ML; Block GD; Amiot BP
Ann N Y Acad Sci; 1999 Jun; 875():340-52. PubMed ID: 10415580
[TBL] [Abstract][Full Text] [Related]
4. Intracranial pressure observations in a canine model of acute liver failure supported by a bioartificial liver support system.
Patzer JF; Lopez RC; Aggarwal S
Artif Organs; 2007 Nov; 31(11):834-9. PubMed ID: 18001393
[TBL] [Abstract][Full Text] [Related]
5. An improved model of galactosamine-induced fulminant hepatic failure in the pig.
Kalpana K; Ong HS; Soo KC; Tan SY; Prema Raj J
J Surg Res; 1999 Apr; 82(2):121-30. PubMed ID: 10090819
[TBL] [Abstract][Full Text] [Related]
6. Gel-entrapment bioartificial liver therapy in galactosamine hepatitis.
Sielaff TD; Hu MY; Amiot B; Rollins MD; Rao S; McGuire B; Bloomer JR; Hu WS; Cerra FB
J Surg Res; 1995 Jul; 59(1):179-84. PubMed ID: 7630125
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of neutrophil elastase inhibitor (FR136706) in lethal acute liver failure induced by D-galactosamine and lipopolysaccharide in rats.
Uchida Y; Kaibori M; Hijikawa T; Ishizaki M; Ozaki T; Tanaka H; Matsui K; Tokuhara K; Kwon AH; Kamiyama Y; Okumura T
J Surg Res; 2008 Mar; 145(1):57-65. PubMed ID: 17936791
[TBL] [Abstract][Full Text] [Related]
8. A surgical model of fulminant hepatic failure in rabbits.
Hung KC; Yong CC; Chen YS; Eng HL; Kuo FY; Lin CC; Young TH; Kobayashi E; Chen CL; Wang CC
Liver Int; 2007 Dec; 27(10):1333-41. PubMed ID: 18036098
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-I prevents lethal acute liver failure induced by D-galactosamine and lipopolysaccharide in rats.
Inoue T; Horiai H; Aoki C; Kawamura I; Ota M; Mizuhara H; Tomoi M; Mutoh S
In Vivo; 2003; 17(3):293-9. PubMed ID: 12929583
[TBL] [Abstract][Full Text] [Related]
10. [Establishment of a D-galactosamine/lipopolysaccharide induced acute-on-chronic liver failure model in rats].
Liu XH; Chen Y; Wang TL; Lu J; Zhang LJ; Song CZ; Zhang J; Duan ZP
Zhonghua Gan Zang Bing Za Zhi; 2007 Oct; 15(10):771-5. PubMed ID: 17963606
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of double-filtration plasmapheretic cross-circulation with a high-permeability membrane using canine harvested liver in porcine fulminant hepatic failure model.
Ishizawa Y; Totsuka E; Umehara M; Nishimura A; Ono H; Sasaki M
Transplant Proc; 2004 Oct; 36(8):2344-8. PubMed ID: 15561244
[TBL] [Abstract][Full Text] [Related]
12. [Establishment of a porcine model of acute hepatic failure by intraportal injection of D-galactosamine and lipopolysaccharide].
Peng CH; Xiao WD; Wu WD; Zhou GW; Zhang MJ; Shu M; Chen HX; Li HW
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1464-7. PubMed ID: 16061023
[TBL] [Abstract][Full Text] [Related]
13. Galactosamine-induced fulminant hepatic necrosis in unanesthetized canines.
Diaz-Buxo JA; Blumenthal S; Hayes D; Gores P; Gordon B
Hepatology; 1997 Apr; 25(4):950-7. PubMed ID: 9096603
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a bioartificial liver based on a nonwoven fabric bioreactor with porcine hepatocytes in pigs.
Li LJ; Du WB; Zhang YM; Li J; Pan XP; Chen JJ; Cao HC; Chen Y; Chen YM
J Hepatol; 2006 Feb; 44(2):317-24. PubMed ID: 16356580
[TBL] [Abstract][Full Text] [Related]
15. Effect of alanine on D-galactosamine-induced acute liver failure in rats.
Maezono K; Mawatari K; Kajiwara K; Shinkai A; Maki T
Hepatology; 1996 Nov; 24(5):1211-6. PubMed ID: 8903400
[TBL] [Abstract][Full Text] [Related]
16. [Establishment of pig acute liver failure model and the role of pig fibrinogen-like protein 2].
Guo JW; Xi D; Yan WM; Luo XP; Ning Q
Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):691-4. PubMed ID: 19785959
[TBL] [Abstract][Full Text] [Related]
17. Standardization criteria for an ischemic surgical model of acute hepatic failure in pigs.
Nieuwoudt M; Kunnike R; Smuts M; Becker J; Stegmann GF; Van der Walt C; Neser J; Van der Merwe S
Biomaterials; 2006 Jul; 27(20):3836-45. PubMed ID: 16527346
[TBL] [Abstract][Full Text] [Related]
18. A reliable graded acute liver failure model in rats: treatment with internal bioartificial liver.
Xu QX; Ding YT; Qiu YD; Yu DC; Zhang HY
Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):254-8. PubMed ID: 15138121
[TBL] [Abstract][Full Text] [Related]
19. Effects of prostaglandin E(1) on the efficacy of xenogeneic extracorporeal pig liver perfusion in a canine model of acute liver failure.
Takeyama O; Ikai I; Yagi T; Satoh S; Kanazawa A; Uesugi T; Nishitai R; Okabe H; Katsura N; Terajima H; Yamaoka Y
Liver Transpl; 2001 Jun; 7(6):526-32. PubMed ID: 11443582
[TBL] [Abstract][Full Text] [Related]
20. Preclinical evaluation of the Excorp Medical, Inc, Bioartificial Liver Support System.
Patzer JF; Mazariegos GV; Lopez R;
J Am Coll Surg; 2002 Sep; 195(3):299-310. PubMed ID: 12229936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
